Assessment of platelet function assays

…, JD Page, LP Feigen, DM Lansky, AK Salyers - American heart …, 1998 - Elsevier
Optical aggregometry, traditionally used to assess platelet function, is highly dependent on
sample preparation and technical procedure; as a result, data from various laboratories can …

Central and peripheral sites of action for CB2 receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats

…, BA Hooker, CZ Zhu, AK Salyers… - British journal of …, 2011 - Wiley Online Library
BACKGROUND AND PURPOSE Cannabinoid CB 2 receptor activation by selective agonists
has been shown to produce analgesic effects in preclinical models of inflammatory and …

In vitro and in vivo characterization of A‐796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models

…, CZ Zhu, M Pai, P Chandran, AK Salyers… - British journal of …, 2008 - Wiley Online Library
Background and purpose: Selective cannabinoid CB 2 receptor agonists have demonstrated
analgesic activity across multiple preclinical pain models. AM1241 is an indole derivative …

H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in rats

GC Hsieh, P Chandran, AK Salyers, M Pai… - Pharmacology …, 2010 - Elsevier
The histamine H 4 receptor (H 4 R) is expressed primarily on cells involved in inflammation
and immune responses. To determine the potential role of H 4 R in pain transmission, the …

Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2, 2, 3, 3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4, 5-dimethyl-3H …

…, BA Hooker, M Pai, EJ Wensink, AK Salyers… - … of Pharmacology and …, 2009 - ASPET
… , A-836339 also failed to displace [ 3 H]DAMGO at the μ-opioid receptor at concentrations
up to 10 μM (data not shown), whereas the μ-opioid receptor ligand naloxone exhibited a K i …

Characterization of nerve growth factor‐induced mechanical and thermal hypersensitivity in rats

…, J Mikusa, EJ Gomez, AK Salyers… - … journal of pain, 2013 - Wiley Online Library
Background Injection of nerve growth factor ( NGF ) produces mechanical and thermal
hypersensitivity in rodents and humans. Treatment with sequestering antibodies demonstrates the …

Pharmacological interruption of acute thrombus formation with minimal hemorrhagic complications by a small molecule tissue factor/factor VIIa inhibitor: comparison to …

OD Suleymanov, JA Szalony, AK Salyers… - … of Pharmacology and …, 2003 - ASPET
This study was designed to evaluate the antithrombotic efficacy and bleeding propensity of a
selective, small-molecule inhibitor of tissue factor/factor VIIa (TF/VIIa) in comparison to small…

Orbofiban: an orally active GPIIb/IIIa platelet receptor antagonist

…, LG Frederick, JD Page, AK Salyers… - Medicinal research …, 2001 - Wiley Online Library
A key role has been established for platelet activation and thrombus formation in the
pathogenesis of acute coronary syndromes, and restenosis after percutaneous interventions. …

Antinociceptive effects of histamine H3 receptor antagonist in the preclinical models of pain in rats and the involvement of central noradrenergic systems

…, M Pai, EJ Wensink, P Chandran, AK Salyers… - Brain research, 2010 - Elsevier
The histamine H 3 receptor is predominantly expressed in the central nervous system and
plays a role in diverse physiological mechanisms. In the present study, the effects of …

SC-54684A: an orally active inhibitor of platelet aggregation

NS Nicholson, SG Panzer-Knodle, AK Salyers… - Circulation, 1995 - Am Heart Assoc
Background Intravenous therapy has been shown to be beneficial in the prevention of acute
platelet-associated thrombotic events. However, orally active agents would be …